Finally, a trial of a cell replacement transplantation strategy is enrolling people with PD carrying mutations in the gene for parkin, hypothesizing these individuals will benefit most since PD caused by parkin mutations appear to be more purely linked to dopaminergic cell loss (The Michael J. Fox Foundation, 2022). This evidence concerns the gene PRKN and Parkinson disease.